Innate Pharma (IPHA) FCF Margin (2019 - 2025)
Innate Pharma (IPHA) posted quarterly FCF Margin of 5.02% for Q4 2025, up 193.0% year-on-year from 1.71% in Q4 2024, and up 62.16% on a QoQ basis from 3.1% in Q4 2024.
Innate Pharma (IPHA) FCF Margin (2019 - 2025) Analysis & Trends
Innate Pharma (IPHA) has reported FCF Margin for 7 consecutive years, with 5.02% the latest figure, recorded in Q4 2025.
- Quarterly FCF Margin rose 193.0% year-over-year to 5.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.33% (down 10.0% YoY) and the FY2025 annual result came in at 587.4%, down 55118.0% from the prior year.
- FCF Margin grew to 5.02% in Q4 2025 per IPHA's latest filing, from 3.1% in the prior quarter.
- Over the last five years, FCF Margin for IPHA reached as high as 7.67% in Q4 2021 and fell as low as 3.41% in Q2 2024.
- A 5-year average of 1.63% and a median of 0.34% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2021 — FCF Margin jumped 605 bps — and 2022, when it slumped 767 bps.
- Year by year, FCF Margin stood at 7.67% in 2021, then tumbled by 100 bps to 0.0% in 2022, then surged by 62574 bps to 0.68% in 2023, then soared by 358 bps to 3.1% in 2024, then soared by 62 bps to 5.02% in 2025.
- According to Business Quant data, FCF Margin over the past three periods registered 5.02%, 3.1%, and 3.41% for Q4 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Innate Pharma | 157.68 Mn | 157.68 Mn | - | 5.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.02% |
| Dec 31, 2024 | 3.10% |
| Jun 30, 2024 | -3.41% |
| Dec 31, 2023 | 0.68% |
| Jun 30, 2023 | 0.01% |
| Dec 31, 2022 | 0.00% |
| Jun 30, 2022 | 0.01% |
| Dec 31, 2021 | 7.67% |
| Dec 31, 2020 | 1.62% |
| Dec 31, 2019 | 1.84% |